Stella Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	10,687	13,035	9,087	11,485	17,281	-
Market Cap Growth	-38.31%	43.45%	-20.88%	-33.54%	-	-
Enterprise Value	8,576	10,396	7,501	10,146	14,767	-
Last Close Price	314.00	383.00	291.00	387.00	603.00	-
PS Ratio	10.77	13.56	33.78	50.15	172.82	-
PB Ratio	3.69	4.07	3.82	4.17	5.61	-
P/TBV Ratio	3.74	4.13	3.91	4.27	5.74	-
P/FCF Ratio	-	95.85	-	-	-	-
P/OCF Ratio	-	93.11	-	-	-	-
EV/Sales Ratio	8.64	10.82	27.88	44.31	147.68	-
EV/FCF Ratio	-11.67	76.44	-	-	-	-
Debt / Equity Ratio	0.24	0.24	0.39	0.40	0.41	6.14
Debt / FCF Ratio	-	5.63	-	-	-	-
Asset Turnover	0.20	0.21	0.07	0.05	0.03	0.09
Inventory Turnover	0.11	0.10	0.05	0.03	0.03	0.07
Quick Ratio	11.92	10.05	5.34	6.58	10.69	4.09
Current Ratio	16.63	13.44	7.98	9.01	13.56	5.67
Return on Equity (ROE)	-5.99%	-5.01%	-29.76%	-26.68%	-46.36%	-143.26%
Return on Assets (ROA)	-1.48%	-1.22%	-11.66%	-11.14%	-13.69%	-18.08%
Return on Capital Employed (ROCE)	-2.60%	-1.80%	-22.60%	-20.60%	-16.80%	-39.40%
Earnings Yield	-1.67%	-1.07%	-8.40%	-6.77%	-4.44%	-
FCF Yield	-6.88%	1.04%	-9.75%	-7.43%	-6.52%	-
Buyback Yield / Dilution	-6.40%	-7.76%	-7.27%	-2.83%	-40.17%	-28.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.